
|Articles|February 17, 2017
PBM Advocacy for DIR Fees Highlight AJPB Week in Review
Author(s)Davy James, Managing Editor
Top articles of the week on The American Journal of Pharmacy Benefits.
Advertisement
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Poherdy, First Biosimilar to Perjeta, For HER2 Breast Cancer Indications
2
Ziftomenib Receives FDA Approval for Acute Myeloid Leukemia With NPM1 Mutations
3
The Dual Burden of CAR T-Cell Therapy: Financial and Time Toxicity in the Era of Precision Oncology
4
Study Finds Similar Outcomes Between hMPV and RSV Hospitalizations
5






















































































































































































































